PT-141 / Tadalafil / Oxytocin – Gel Troche

(Ship Cold)

Available Dosage Strengths

2 mg / 10 mg / 100 IU

Want to Prescribe?

Disclaimer: Images are for reference only; actual products may vary.

Product Overview

PT-1411,2

Bremelanotide, also known as PT-141, is a melanocortin receptor (MCR) agonist. It is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to:

  • A co-existing medical or psychiatric condition,
  • Problems with the relationship, or the effects of medication or drug substance

 

Tadalafil Description3,4

Tadalafil, a phosphodiesterase type 5 (PDE5) inhibitor, has a mean terminal half-life of over 17 hours. This half-life is much longer than other PDE-5 inhibitors. This half-life allows for once-daily or on-demand dosing. The drug is indicated for the treatment of pulmonary arterial hypertension (PAH), erectile dysfunction (ED), benign prostatic hypertrophy (BPH), or the concurrent treatment of ED and BPH.

 

Oxytocin Description6-11

Oxytocin is produced in the hypothalamus and stored in the posterior portion of the pituitary gland. Oxytocin is made synthetically and has activity identical to natural oxytocin. Oxytocin stimulates contraction of smooth muscle in the uterus during labor and stimulates the alveolar ducts to eject milk after it has been produced in the breast. Thus, because of the actions of oxytocin on the uterus, it has been used to induce labor, aid in the delivery of the placenta, and control postpartum bleeding. Oxytocin has also been associated with social bonding, mood regulation and sexual functioning.

PT-1411,2

Bremelanotide (PT-141), a MCR agonist, non-selectively works on several receptor subtypes MC1R-MC5R in the central nervous system. MC1R and MC4R are thought to be the most relevant. MC4R are commonly present in the central nervous system. Although the mechanism of action is not fully elucidated, the drug is thought to activate pathways in the brain that are involved in sexual responses.

 

 

Tadalafil3-5

Phosphodiesterase (PDE) has many isoforms and is an enzyme that has many functions in the body including degrading the effect of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). PDE5 is an enzyme that is found in many parts of the body including in the smooth muscle of the corpus cavernosum, prostate, bladder, the vascular and visceral smooth muscle, skeletal muscle, urethra, platelets, kidney, lung, cerebellum, heart, liver, testis, seminal vesicle, and pancreas. Tadalafil is a selective inhibitor of PDE5, the enzyme responsible for the degradation of cGMP. The drug has selective activity on PDE5 than other phosphodiesterase isoforms. Tadalafil activity on PDE5 is more than 10,000-fold more than for PDE1, PDE2, PDE4, and PDE7 enzymes. Increased cGMP leads to smooth muscle relaxation in the corpus cavernosum which can help in maintaining an erection.

 

Oxytocin6-11

Oxytocin causes G-protein coupled receptors to increase intracellular calcium which leads to uterine contraction. The stimulation of uterine contractions causes more oxytocin to be released. As more oxytocin is released it positively influences even more release of oxytocin. This release of oxytocin is called positive feedback which is much different than how many hormones work in the endocrine system. Oxytocin administered exogenously causes the same response as endogenously produced oxytocin. Not only does oxytocin stimulate uterine contractions, but it also causes contractions of myoepithelial cells in the alveolar ducts found in female breast tissue. These contractions force milk from these ducts into even larger sinuses, which subsequently enables milk expulsion. When a baby attempts to latch onto the mother’s breast it causes oxytocin secretion into the blood in the same manner as vaginal delivery; instead of uterine contractions, milk is ejected from the breast. Similar to the actions of oxytocin in the uterus to stimulate contractions during delivery, milk-ejection from breast tissue occurs due to positive feedback. In the brain, it is proposed that oxytocin stimulates social and sexual function by its activity in many areas of the brain including its activity on neurotransmitters.

PT-1411,2

Common

  • Gastrointestinal including nausea and vomiting
  • Increased blood pressure
  • Hyperpigmentation

Tadalafil3-5

Common 

  • Headache
  • Dyspepsia
  • Flushing
  • Back pain and myalgia (typically delayed onset, resolving within 48 hours)
  • Nasal congestion
  • Pain in limbs

Oxytocin6-11

Common

  • Loss of appetite
  • Nausea, vomiting
  • Stomach pain.

PT-1411,2

Contraindications:

  • Known hypersensitivity to bremelanotide or any component of the formulation
  • Patients with uncontrolled hypertension and cardiovascular disease
  • Pregnancy not recommended when taking bremelanotide

Precautions:

  • Use caution in patients with renal or hepatic impairment

 

Tadalafil3-5

Contraindications

  • Known hypersensitivity to tadalafil or tablet excipients
  • Use of nitrates and guanylate cyclase (GC) stimulators therapy, such as riociguat due to risk of life-threatening hypotension

Precautions

  • Use with caution in patients with:
  • Severe hepatic impairment (Child-Pugh Class C)
  • Severe renal impairment (creatinine clearance <30 mL/min)
  • Retinitis pigmentosa (rare inherited retinal disorder)
  • History of NAION (non-arteritic anterior ischemic optic neuropathy)
  • Recent history of myocardial infarction, stroke, or unstable angina

 

Oxytocin6-11

Contraindications

  • Known hypersensitivity to oxytocin
  • Pregnancy 1st or 2nd trimester

Precautions

  • Oxytocin may possess antidiuretic effects—extended administration may increase risk of fluid overload
  • Cardiovascular disease, due to oxytocin’s potential vasopressor effects

Store in the refrigerator at 2°C–8°C (36°F–46°F). Protect from light, heat, and moisture. Keep out of reach of children and pets.

  1. Bremelanotide package insert. www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf
  2. Clinical Pharmacology bremelanotide clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  3. Tadalafil Prescribing Information – Eli Lilly. www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20s21lbl.pdf Revised October 2011. Accessed May 31, 2025
  4. Clinical Pharmacology Tadalafil clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  5. Padda IS, Tripp J. Phosphodiesterase Inhibitors. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559276/
  6. Oxytocin Prescribing Information – Fresenius Kabi. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018248s049lbl.pdf Revised September 2022. Accessed May 31, 2025
  7. Clinical Pharmacology Oxytocin clinical monograph 2025 https://www.clinicalkey.com/pharmacology/
  8. Osilla EV, Patel P, Sharma S. Oxytocin. [Updated 2025 Feb 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507848/
  9. Kou J, Lan C, Zhang Y, Wang Q, Zhou F, Zhao Z, Montag C, Yao S, Becker B, Kendrick KM. In the nose or on the tongue? Contrasting motivational effects of oral and intranasal oxytocin on arousal and reward during social processing. Transl Psychiatry. 2021 Feb 4;11(1):94.
  10. Zhuang Q, Zheng X, Yao S, Zhao W, Becker B, Xu X, Kendrick KM. Oral Administration of Oxytocin, Like Intranasal Administration, Decreases Top-Down Social Attention. Int J Neuropsychopharmacol. 2022 Nov 17;25(11):912-923.
  11. Quintana DS, Glaser BD, Kang H, Kildal ESM, Audunsdottir K, Sartorius AM, Barth C. The interplay of oxytocin and sex hormones. Neurosci Biobehav Rev. 2024 Aug;163:105765.

This sheet is a summary. It may not cover all possible drug information about this product. Call your doctor for medical advice and/or about side effects. You may report side effects to the FDA at 1-800-FDA-1088.  A Wells Pharmacy Network pharmacist will be happy to answer any questions. For consultation, please call 1-800-622-4510.

EXPLORE MORE

Related Medications

We deliver your orders fast and with complete discretion, straight to your door.

We're licensed to ship nationwide

Our mission is to elevate compounding industry standards through a unique combination of superior science and service.

Ready to get started?